Biovista Inc., Charlottesville, July 7, 2010: Biovista today announced that it will be presenting at the 8th International Conference on Pathways, Networks, and Systems Medicine to be held at the Sheraton rhodes hotel in Rhodes, July 9 – 14, 2010. Dr Andreas Persidis, CEO of Biovista Inc. will present on Sunday 11 July, 11:45am local … Read More
News
Drug Repositioning: Extracting Added Value from Prior R&D Investments
Biovista profiled in latest Insight Pharma report “Drug Repositioning:Extracting Added Value from Prior R&D Investments”. Drug repositioning is also known as drug repurposing, reprofiling, or retasking. In “on-target repurposing,” a drug’s known pharmacological mechanism is applied to a different therapeutic indication than that for which it was initially developed. Even more innovative is “off-target repurposing, ” … Read More
Biovista at OneMedForum New York 2010
Graham Anthony, CFO of Biovista, Inc., presents at the OneMedForum New York 2010.
BioWorld: Obesity Report : Tipping the Market Scales with Biotech & Med-Tech Regimens
BioWorld & Medical Device Daily BioVista Inc. has drugs in various stages of research and preclinical development for eye disorders, diabetes and obesity. According to its website, the Charlottesville, Va.-based company has identified four novel targets involved in diabetes and obesity that lend them- selves to the development of RNAi drugs. Using artificial intelligence (AI), … Read More
Biovista sponsors Drug Redevelopment and Product Pipeline Enhancement Conference
Charlottesville, VA (22 February 2010): Biovista Inc. announced today that it is sponsoring the 2010 Drug Redevelopment and Product Pipeline Enhancement Conference taking place in London, February 25 and 26, 2010. This open business platform which will be held at the London Marriott Regents Park hotel, offers pharmaceutical and biotech entities the opportunity to showcase their latest … Read More